NASDAQ Global Select • Healthcare • Medical - Devices • US • USD
Abiomed, Inc. (ABMD) has a consensus analyst rating of Hold, based on 18 analysts covering the stock. Of those, 8 recommend buying, 10 recommend holding, and 0 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.